Validation of the Residual Cancer Burden Index as a prognostic tool in women with locally advanced breast cancer treated with neoadjuvant chemotherapy (2023)
- Authors:
- USP affiliated authors: GONÇALVES, RODRIGO - FM ; FILASSI, JOSE ROBERTO - FM ; SOARES JÚNIOR, JOSÉ MARIA - FM ; BARACAT, EDMUND CHADA - FM
- Unidade: FM
- DOI: 10.1136/jclinpath-2021-207771
- Subjects: PROGNÓSTICO; TERAPIA COMBINADA; NEOPLASIAS MAMÁRIAS; QUIMIOTERAPIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of clinical pathology
- ISSN: 0021-9746
- Volume/Número/Paginação/Ano: v. 76, n. 4, p. 239-243, 2023
- Status:
- Nenhuma versão em acesso aberto identificada
-
ABNT
CUNHA, Juliana Pierobon Gomes da et al. Validation of the Residual Cancer Burden Index as a prognostic tool in women with locally advanced breast cancer treated with neoadjuvant chemotherapy. Journal of clinical pathology. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://observatorio.fm.usp.br/handle/OPI/53967. Acesso em: 14 abr. 2026. , 2023 -
APA
Cunha, J. P. G. da, Goncalves, R., Silva, F., Aguiar, F. N., Mota, B. S., Chequin, B. B., et al. (2023). Validation of the Residual Cancer Burden Index as a prognostic tool in women with locally advanced breast cancer treated with neoadjuvant chemotherapy. Journal of clinical pathology. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1136/jclinpath-2021-207771 -
NLM
Cunha JPG da, Goncalves R, Silva F, Aguiar FN, Mota BS, Chequin BB, Soares Junior JM, Baracat EC, Filassi JR. Validation of the Residual Cancer Burden Index as a prognostic tool in women with locally advanced breast cancer treated with neoadjuvant chemotherapy [Internet]. Journal of clinical pathology. 2023 ; 76( 4): 239-243.[citado 2026 abr. 14 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53967 -
Vancouver
Cunha JPG da, Goncalves R, Silva F, Aguiar FN, Mota BS, Chequin BB, Soares Junior JM, Baracat EC, Filassi JR. Validation of the Residual Cancer Burden Index as a prognostic tool in women with locally advanced breast cancer treated with neoadjuvant chemotherapy [Internet]. Journal of clinical pathology. 2023 ; 76( 4): 239-243.[citado 2026 abr. 14 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53967 - Measurement of extracapsular extension in sentinel lymph node as a possible predictor of residual axillary disease in breast cancer
- Phyllodes tumors of the breast: a comprehensive review of diagnosis, treatment, and follow-up
- Mapping delays in breast câncer care during COVID-19: lessons from the Brazilian Public Health System (SUS). [Editorial]
- Effects of preoperative magnetic resonance image on survival rates and surgical planning in breast cancer conservative surgery: randomized controlled trial (BREAST-MRI trial)
- Prognostic implications of magee equation 3 and residual câncer burden in patients receiving neoadjuvant chemotherapy for hormone receptor-positive HER2-negative breast cãncer
- Characteristics and prognosis of young breast cancer patients treated in a public comprehensive cancer centre in Brazil: a retrospective cohort study
- Hormônio liberador de gonadotrofina
- FOXO3a deregulation in uterine smooth muscle tumors
- Vitamin D and in vitro fertilization: a systematic review
- Oral probiotics and vaginal microbiome in post-menopause women. [Editorial]: an opinion for the improvement of natural therapies in gynecology
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
